Morgan Stanley analyst Mark Purcell lowered the firm’s price target on GSK to 1,535 GBp from 1,650 GBp and keeps an Equal Weight rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GSK:
- Jim Simons’ Hedge Fund Renaissance Technologies is Buying These Stocks Now
- Biogen price target raised to $315 from $300 at Oppenheimer
- GSK says GSK3036656 demonstrated early bactericidal activity in Phase IIa study
- Biotech Alert: Searches spiking for these stocks today
- Sanofi-GSK next-generation COVID-19 booster vaccine approved by EC